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After completing a Ph.D. on fly 
genetics in the laboratory of Pedro 
Ripoll at the Centre for Molecular 
Biology (CBM, Madrid, Spain), 
Cayetano Gonzalez moved to David 
Glover’s lab in the UK, first at Imperial 
College and later as a CRC Joint 
Principal Investigator at Dundee. In 
1994, he took his first independent 
position, as a Group Leader at EMBL 
(Heidelberg, Germany), and his hair 
went white. After the customary 
nine-year period at EMBL, he moved 
to CNIO (Madrid), but he moved out 
only nine months later to his present 
post at the Institute for Research in 
Biomedicine (IRB-Barcelona), where 
he is a Research Professor funded 
by the Catalan Institute for Research 
and Advanced Studies (ICREA), 
leading the Cell Division Group. They 
use Drosophila as a model system to 
elucidate the role of centrosomes in 
cell division and development and to 
learn how stem-cell-derived tumours 
arise and grow. 
What turned you on to biology in 
the first place? Quite simply, I failed 
to enter medical school and so I went 
for my second favourite option of 
biology school. I got the opportunity to 
enter med. school one year later, but 
by then I had realized that my vocation 
was not as strong as I had thought and 
that exploring the mechanics of life 
excited me much more than acting as 
a medic. Serendipity had put me on the 
right path.
Do you have a favourite paper? 
Picking just one is impossible. I love 
the classical, mostly forgotten, papers 
describing the construction of new 
chromosomes with only the help 
of X-rays and highly sophisticated 
Drosophila genetics. Novitski’s 
synthesis of C(2)EN, a chromosome 
that carries two copies of the second 
chromosome is a masterpiece of 
genetic engineering, and the paper 
reporting it is a delight to read, as it 
sets a challenging goal, and takes 
the reader through the complex 
steps required to eventually deliver 
the new creation. I also enjoyed very 
much the paper by Lindsley, Sandler, 
Baker, Carpenter and many others on 
Q & A segmental aneuploidy and the genetic gross structure of the Drosophila 
genome — the first ‘genome wide’ 
analysis (in 1972!) of the effect of 
duplications and hemizygosis in the 
development of a higher eukaryote.
Has any key event helped your 
career? Many. I explained before 
the serendipitous path that took me 
into biology. Then, like most male 
youngsters of my generation in Spain, 
I was conscripted for compulsory 
military service for fifteen months. 
At that time, I can assure you, I did 
not regard this experience as a lucky 
one. But this unsolicited ‘holiday’ 
definitely prevented me from taking a 
not- so- exciting job offer and helped 
make sure I was in the right place at 
the right time to get an offer to join 
Pedro Ripoll´s lab, undoubtedly the 
single most important stroke of luck 
in my scientific career. Later on, luck 
came again to my rescue at certain 
critical times; I sometimes wonder 
what I have actually contributed to the 
way my career has developed.
Any memorable quotes? I will give 
you three that I often use. The first is 
a classic: “never trust a stock label” 
(Michael Ashburner). It refers to the 
labels that carry the information on the 
genotype of a stock of mutant flies. 
Picking up some of these stocks is the 
starting point of experiments that may 
last for months, or years. If only people 
engraved this most valuable piece of 
advise in their minds! Fly stock labels 
are not birth certificates. The number of 
hours wasted by researchers ignoring 
this warning is incommensurable. The 
second is Lewis Wolpert’s remark 
about no-phenotype knockout mice: 
“have you taken your mice to the 
opera? Can they still tell Wagner from 
Mozart?” Applicable to all experimental 
model systems, this is a much-needed 
reminder of the fact that the presence 
or lack of mutant phenotypes depends 
on the level of detail and quality of the 
phenotypic analysis. I came across the 
third relatively recently. It is actually 
from Sydney Brenner, but I learnt 
about it in a review by Peter Lawrence 
“there is a difference between theories 
being correct and theories being true”. 
Biological modellers should not forget 
this verity. 
Any mistakes or failed experiments 
you care to remember? Too 
many to recount! There is one that I remember vividly. I found that several 
antibodies raised against a number 
of cell-cycle control proteins showed 
positive staining in fully mature 
sperm. Remarkably, they labelled 
very precisely antibody-specific 
subdomains within the acrosome. 
Pre- immune serum, or serum that 
had been pre-absorbed with the 
immunogen were negative. So, 
everything was looking good until to 
my surprise and dismay I found that 
just about every antibody available in 
the lab gave similar results. It became 
clear to me then that I had spent 
months (many months) chasing a wild 
goose. I still do not understand those 
results. Since then, I take any ‘specific 
antibody staining’ with considerable 
scepticism.
Do you have a scientific hero? 
Heroes certainly not, God forbid, but I 
do admire many scientists, dead and 
alive, who over the centuries have had 
the right combination of independence, 
originality, determination, critical mind, 
wit and luck that it takes to make a 
major breakthrough. For some reason, 
my deepest admiration goes to my 
fellow countryman Don Santiago 
Ramón y Cajal. The conditions he 
worked under were appalling; his 
contributions, revolutionary. I have had 
the opportunity of seeing some of his 
original drawings with his handwritten 
annotations. Far out!
What do you think are the big 
questions to be answered next in 
your field? I wish I knew. It is not as 
simple as it may look, because often, 
big questions are only recognised 
as such only after the answer is 
known. We, like many others, are very 
interested in the possible role of stem 
cells as the cell-of-origin of certain 
tumours. We, unlike others, have 
great expectations that Drosophila 
stem cells will help us to elucidate the 
mechanisms that may drive these cells 
into malignancy. As it has been the 
case in other areas of molecular, cell, 
and developmental biology, we hope 
that what we learn about cancer in the 
fly will help us to understand cancer 
in other organisms we are a lot more 
concerned about.
Would you care to share with us 
your view on journals and the 
peer reviewing system? That is the 
tricky one I guess. I think that most 
colleagues will agree that there is 
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himself, benefited in turn from the 
teachings of the British founders of 
modern neurophysiology, Charles Scott 
Sherrington and Edgar Douglas Adrian. 
Origins
In the early years of the past century, 
Italian science could pride itself on 
having produced some of the best 
students of the nervous system in the 
world. In histology, Camillo Golgi from 
the University of Pavia was awarded 
the 1906 Nobel prize in Physiology or 
Medicine for his discoveries concerning 
the fine morphology of the nervous 
tissue [1]. In physiology, Angelo Mosso 
from the University of Turin was the first 
to show regional changes in the blood 
flow through the brain during responses 
to sensory stimuli, mental work and 
emotional experiences [2], providing 
the basic rationale for the functional 
neuroimaging of the present day [3]. 
Important discoveries were also made 
by Luigi Luciani, who taught Physiology 
in Siena, Florence and Rome, and 
pioneered the localization of functions 
in the cerebral cortex and cerebellum 
[4]. Surprisingly, the scientific 
interactions between Golgi and the 
two great neurophysiologists of his 
time were very limited, and practically 
irrelevant for the development of their 
respective fields of research. Like 
Cajal, Golgi paid little attention to the 
findings of the physiologists, because 
he felt that the conclusions drawn 
from such findings were too indirect 
and far- fetched, and that only the 
British roots of Italian 
neurophysiology 
in the early 20th 
century
Giovanni Berlucchi
The recent Congress of the Italian 
Society of Neuroscience in Verona 
attracted several hundred participants, 
attesting to the vitality of a scientific 
enterprise that was started 23 
years ago with the Society’s first 
meeting in Rome. During the first 
Congress in Rome, four eminent 
Italian scientists were appointed 
honorary members of the Society 
in recognition of their outstanding 
contributions to neuroscience: the 
neurobiologist Rita Levi-Montalcini, 
the neuropharmacologists Daniele 
Bovet and Vittorio Erspamer, and 
the neurophysiologist Giuseppe 
Moruzzi. Their world-famous work 
inspired and provided the climate that 
encouraged the development of the 
neurosciences in Italy, and inspires 
Italian neuroscientists to this day. I 
have benefited from Moruzzi’s teaching 
throughout my scientific career, and my 
purpose here is to tell how Moruzzi’s 
teacher Mario Camis, and Moruzzi 
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Figure 1. Mario Camis in his monastic cell at the St. Dominic convent in Bologna.something wrong with the current 
system. Everyone has one or more 
nightmare stories about certain 
papers. Once, a paper of ours that 
after many months’ worth of hard work 
and two rounds of revision eventually 
got the explicit approval of all three 
referees was eventually rejected on 
the astonishing grounds that the editor 
did not find it sexy enough (sic). Since 
then, I anxiously search for the sexy 
side of every paper I read. Still I have 
not found any — that is aside from 
those on courtship behaviour and 
mating in Drosophila. Then, there are 
the cases in which referees do not do 
their job properly. It happens now and 
then, and is infuriating. The solution 
is not trivial, but something must be 
done. I fully agree with Conly Rieder 
who, in this same column proposed 
first, that referees should be paid, and 
second, that they should be proud 
enough of their work to be happy to 
see their signed reports published 
side-by-side with the article. This 
solution is not a panacea, but I believe 
that it would ameliorate the problem. 
If you knew what you know earlier 
on, would you still pursue the 
same career? If I had the impossible 
chance of starting up a new carrier 
again, I would certainly try something 
else. There are so many worlds 
to be explored — architecture, 
nanotechnology, many more — that 
it would seem silly to waste the 
opportunity. If the question is more 
along the line of whether I regret 
having pursued a career in biology, 
then the answer is positively not. It has 
not come without tough moments, but 
the rewards are priceless. Anyone who 
has had the pleasure of discovering 
a new molecule, a new function, a 
new process, will agree. I actually 
think that we scientists running our 
own independent research are, in 
many regards, privileged people. To 
prospective new colleagues I would 
strongly advise (I actually do every time 
I have the opportunity to do so) that 
a Ph.D. is not what comes naturally 
after graduation, or the kind of job you 
embark on for lack of anything better. 
This career requires lots of dedication. 
If you do not long for it and feel 
passionate about it, you will be much 
better off doing something else.
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